Leukemia
Early allogeneic stem-cell transplantation used to treat leukemia
Published in Blood Weekly, January 12th, 2006
"We analyzed the impact of alloSCT as an early consolidation for young patients with acute myeloblastic leukemia in first complete remission (CR1) through four successive protocols. Of the 472 patients who achieved CR1, 182 (38%) had an HLA-identical sibling (donor group), and alloSCT was performed in 171 patients (94%). Of the 290 patients without donor (no-donor group), 62% received an autologous SCT," scientists in France reported.
"In an intent-to-treat analysis based on donor availability, the overall 10-year survival...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-01-12)
More Articles from Blood Weekly
- Cord Blood
Unrelated cord blood transplant successful in children with Shwachman-Diamond syndrome - Liver Regeneration
Partial hepatectomy induces mobilization of stem cells in healthy liver donors - Stem Cell Research
Antibody-conjugated magnetoliposomes rapidly and efficiently expand mesenchymal stem cells - Tissue Engineering
Keratinocytes and dermal fibroblasts cultured on PLGA microspheres regenerates skin - Tissue Engineering
Pulsed low intensity ultrasound stimulates intervertebral disc cell cellular metabolism - Acute Lymphoblastic Leukemia
European study confirms efficacy of clofarabine in pediatric patients with ALL - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
